Vertex to buy Alpine Immune Sciences for $4.9 billion
Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the immune system, for $4.9 billion.
Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the immune system, for $4.9 billion.
Jeffrey Davis and Rachel Stauffer highlight telehealth’s legislative history and describe some of its regulatory challenges going forward.
Recent readouts from early stage clinical trials show that what’s going into Phase 1 clinical trial is more successful, Powell said told the audience at…
Casting harm reduction programs for drug users as inherently opposed to order and public safety is a false choice, addiction experts said at #STATBreakthrough.
The Official Site of Major League Baseball
Last 3 seats at 6% discount in May 2024. COUPON CODE: ACVTEGCM Six Month Zero Cost EMI on 13 Indian Credit Cards. Check Offers link…
Aruni Bhatnagar, Ph.D., FAHA; Professor of Medicine; Chief, Division of Environmental Medicine; Smith and Lucille Gibson Professor of Medicine; Director, Chr…
Abigail S. Chan, M.D., Assistant Professor of Medicine in the Division of Medical Oncology & Hematology at the University of Louisville School of Medicine an…
It’s unconscionable that children should die of uncontrolled asthma in the U.S. when there are cheap and effective medications available to control this disease.
When it comes to bringing an experimental drug to market and selling it, Novo Nordisk, maker of the weight loss drug Wegovy, is tops, according…
Two health committees are presenting a unified front when it comes to extending pandemic-era telehealth flexibilities for Medicare patients.